BIO-key International received a notice from Nasdaq stating the company failed to timely file its Form 10-Q for the quarter ended March 31, 2026, violating Listing Rule 5250(c)(1). The Nasdaq Hearing Panel will determine whether the company maintains its listing on Nasdaq Capital Market.